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Summary.-We have shown that thioamides are incorporated as false precursors
into melanin during its synthesis. To be clinically useful in the diagnosis or therapy
of melanotic melanomas, they would have to be tagged with an appropriate isotope
or possibly a cytotoxic moiety. 125I-Thiouracil (125I-TU) is here shown to be
accumulated in the melanin of melanotic melanomas transplanted into mice in a
similar way as is 14C-thiouracil (14C-TU). 125I-TU gives tumour/liver and
tumour/muscleratios upto22 and778respectively, at4days after administration.125I-
TU is accumulated by melanoma cells in vitro more effectively than 14C-TU (1251-
TU/14C-TU, 2 7), while the in vivo accumulation into melanomas is slightly lower for
1251-TU as compared to 14C-TU (125I-TU/14C-TU, 035). This appears to be due to a
partial deiodination (<14% of the dose within 4 days) and probably a more rapid
excretion of 125I-TU or its metabolite(s). The accumulation of radioactivity in the
thyroid can essentially be eliminated by pretreatment with potassium iodide and/or
thyroxine. 1251-Propylthiouracil is also accumulated in melanotic melanoma cells in
vivo and in vitro, but at a lower level than in1251 -TU andL4C-TU.
IN EARLIER STUDIES it was shown that
thiouracil and related thioamides, in
addition to their accumulation in the
thyroid, are also incorporated into melanin
when this is synthesized, e.g. in the eyes of
foetuses or young animals and in melanin-
producing tumours (Whittaker, 1971;
Dencker et al., 1979, 1981, 1982). Unlike
drugs such as chloroquine and chlorpro-
mazine (Lindquist & Ullberg, 1972),
thiouracil does not bind to preformed
melanin. If one is interested in finding
drugs that might be clinically useful in
localizing malignant melanomas, which
usually have a high rate of melanin
synthesis, then thioamides may be the
drugs of choice.
To be clinically useful in this respect,
the thioamides would have to be tagged
with a gamma-emitting isotope with a
relatively short half-life. Even if a number
of different isotopes may prove useful, we
have so far considered it most relevant to
work with iodine, for which a number of
isotopes are available.
The aim of this paper is to determine
whether thiouracil labelled with iodine-125
is incorporated into melanotic melanoma
cells in vitro and in vivo similarly to
thiouracil. In addition we have studied the
effects of potassium iodide and thyroxine
on the uptake of radioactivity in the
thyroid after 1251-thiouracil dosing. We
have been able to determine approxi-
mately the extent of deiodination of 1251-
thiouracil in vivo. Finally we have also
studied the distribution of 1251-labelled
propylthiouracil.
MATERIALS AND METHODS
Chemicals
2-Thiouracil (TU) was purchased from
Aldrich-Europe, Belgium, and 6-n-propyl-2-
thiouracil (PTU) from Sigma, St Louis, MO,
U.S.A. Na125I (approx. 15-6 mCi/,4g/I-) wasIODOTHIOURACIL IN MURINE MELANOMAS
obtained from the Radiochemical Centre,
Amersham, U.K. Other chemicals used in the
study were ofanalytical grade and purchased
from regular commercial sources.
Radioiodination
5-125I-2-Thiouracil(125I-TU).-Twobatches
were prepared independently by the
chloramine-T method:
Batch A: To 17 mCi 1251-(6 1l) was added
0 2 ,ug TU in 20tul0-2M phosphate buffer (pH
7.0) and 5 jtl 6mM chloramine-T (in 0-2M
phosphate buffer; pH 7 0). The mixture was
thoroughly shaken. The reaction was allowed
to proceed for 1 h after which 20 ul 01-M
sodium metabisulphite, 50 ,u 0dIM carrier KI
and 200 ,ul 0-05M phosphate buffer (pH 7-4)
were added. The mixture was transferred to a
small column of Sephadex G25 and eluted
with 0-05M phosphate buffer (pH 7 4). Four
different peaks were obtained (for further
analysis see Results).
Batch B: This radioiodination was per-
formed essentially as described by Visser &
Klootwijk (1981). The main deviation was
that the labelling was made at pH 7-5 (instead
of 3-3), in order to increase the yield.
To 1 mCi 1251- (10 Pl) was added 10 ,ul 0-5M
sodium acetate (pH 8-8), 2 jug TU in 10 Il
ethanol and 20 ,ug chloramine-T in 10 ,ul 001M
phosphate buffer (pH 7-4). The final pH ofthe
mixture was 7-5. After 10 min, the reaction
was stopped by the addition of 100 ,ug sodium
metabisulphite in 50 ,ul 0-IM acetic acid. The
separation of 1251-TU from the mixture was
made on Sephadex GIO in a small Pasteur
pipette. Twenty-mM acetic acid containing
0-1mM dithiothreitol was used for elution and
storage. Two peaks were obtained: unreacted
1251- and l251-TU (60%). This is in agreement
with the results ofVisser & Klootwijk (1981).
The specific activity of the 1251-TU was
calculated to be higher than 103 Ci/mmol.
5-1251-6-n-Propyl-2-thiouracil (125I-PTU).-
PTU was radioiodinated in the same way as
Batch B of TU.
Animals
Melanotic Harding-Passey tumours (ob-
tained from AB Leo, Helsingborg, Sweden),
were transplanted into DBA mice. Thus
small pieces of the melanomas from non-
necrotic areas werepassedthrougha mesh into
balanced salt solution (BSS). The cell sus-
pension was then injected s.c. into the
dorsum. When the tumours reached 1 in in 2
.37
diameter, the mice were used for the different
experiments. They were then administered
single i.p. doses ofthe drugs to be studied and
were killed at different intervals after the
injection (usually at 1, 4 and 7 days), by
inhalation ofcarbon dioxide.
Whole-body autoradiography
After killing, the animals were mounted in
a gel ofcarboxylmethyl cellulose and frozen in
hexane, cooled with dry ice. Sections attached
on to tape (No. 810, Minnesota Mining and
Manufacturing Co., U.S.A.) were taken at
different levels of the body (Ullberg, 1954,
1977). The sections were then freeze-dried and
opposed against X-ray film for autoradio-
graphy (section thickness; 20 and 60 ,um).
Scintillation-counting experiments
Quantitative measurements were per-
formed in different ways. Either tissues were
scraped off from thick (200/tm) tape-
fastened sections or were dissected out at
necropsy directly after killing. For 125J, the
tissues were measured in a Packard Auto-
Gamma scintillation spectrometer. For 14C,
melanin-containing tissues were dissolved in
Soluene-100 (Packard), bleached by the
addition of 0-2 ml isopropanol and 0-2 ml of
35% H202 and incubated at 40°C for 30 min,
after which 15 ml of Instagel was added. To
the serum samples was added 1 ml of water
and 10 ml ofInstagel. Remaining tissues were
dissolved in Soluene-350 (Packard), after
which 10 ml of scintillation fluid (4-9 g PPO,
0-1 g dimethyl POPOP per 1 toluene) was
added. The specimens were counted in a
Packard Tricarb 460CD liquid scintillation
spectrometer with the use of an external
standard.
Experimental groups
Distribution studies of 125I-TU.-Tumour-
bearing mice, 3-12 animals in each group,
received single i.p. injections ofvarying radio-
doses of 1251-TU (Batch A) and were killed
after 1, 4 and 7 days. Pieces of tissues from a
number of organs and 2-3 tumourpieces were
excised from each animal. The radioactivity
was measured and calculated as the percent-
age ofthe given dose recovered per g oftissue
(% g dose per g tissue; Table IA). Eight
melanoma-bearing mice received single i.p.
injections of1251-TU (1,170,000 ct/min/gbody
wt. Batch B) and were killed after 1, 4, 7
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TABLE III. Distribution of radioactivity 4 days after administration of Na125I (5 animals)
or 125I-TU (4 animals) to non-tumour-bearing mice. The dose was 400,000 ct/min/g body
wt. Figures in brackets=s.d.
ct/min/mg tissue
Thyroid
43085 (± 9096)
6079 (±1166)
and 14 days, 2 animals in each group. They
were immediately frozen and sectioned for
autoradiography. From the sections (1, 4
and 7 days) tumour areas with high radio-
activity were selected as judged by the auto-
radiograms, plus liver, kidney, lung, muscle,
blood and thyroid for impulse counting (Table
IB).
Comparison between 125I-TU, 125I-PTU
and Na125 I.-1251-TU (Batch B), 1251-PTU
and Na125I were given i.p. in single doses at
400,000 ct/min/g body wt. The 1251-PTU
animals were killed after 1, 4 and 7 days and
the 1251-TU and Nal251 animals were killed
after 4 days. Each group consisted of 3-5
animals (Table II).
Studies on deiodination of 125I-TU in
vivo.-The in vivo loss of 1251 from the 1251-
TU was studied by comparing the thyroidal
accumulation of radioactivity after 1251-TU
and Nal25J administration respectively. Five
animals were injected i.p. with Na125J or 125L-
TU (400,000 ct/min/g body wt., Batch B) and
killed after 4 days for necropsy and gamma
scintillation counting.
The thyroid uptake (in % g dose per g
tissue) ofradioactivity after 1251-TU injection
(Table II) was then reduced by our earlier
value after 14C-thiouracil injection (Dencker et
al., 1982). This gives the approximate contri-
bution offree 1251 to the thyroid radioactivity
concentration after 1251-TU administration.
This accumulation of free 125I can then be
compared to that obtained after 1251 injection
as described above. The percentage deiodina-
tion can thus be easily calculated. As the
amounts ofiodine and thiouracil administered
are very low, it is reasonable to assume that
we have not interfered with thyroid function
by these treatments.
Double isotope studies: comparison between
thedistributionof125I-TUand14C-TU.-Three
animals were injected i.p. with a mixture of
1251-TU (1-4 x 105 ct/min/g, Batch B) and 14C_
TU (1 8 x 105 disintegrations/min/g). After 4
days they were killed and necropsied. Tissue
specimerns were first used for gamma scintil-
lation counting (1251) and then for liquid
scintillation counting (14C) after dissolution of
the tissues, as described earlier. Careful
measures (specific quenching measurements
with windows for the discrimination of 1251
electron radiation) were taken to avoid spill-
over into the 14C channel at the liquid
scintillation counting. For the spill-over that
could still not be avoided, a correction factor
was used. The ratio 1251/14C was then cal-
culated for different tissues of each individual
animal (Table IV).
Uptake of1251-TU and 125I-PTU vs 14C-TU
in Harding-Passey melanoma cells in
vitro.-Harding-Passey melanotic melanoma
cells were grown in a medium containing 50
ml fetal calf serum, 450 ml RPMI 1640 (Flow
Laboratories) 5 ml glutamine (0-2M) with
streptomycin and penicillin added. The
medium was exchanged every 2 days. After
the cells had grown till confluency, 1251-TU
(105 ct/min/ml, Batch B) or 1251-PTU (105
ct/min/ml) plus 14C-TU (105 disintegrations/
min/ml) was added to the medium (5 cultures
each). The cultures were discontinued after 24
h. One ml of the growth medium from each
culture was taken for gamma (1251) and liquid
scintillation counting (14C) afteraddition of10
ml of Instagel. The cultures were washed 4
times in fresh culture medium and then
incubated with 0.25% trypsin and 0 02% Na-
EDTA in PBS for 20 min to loosen the cells.
The cells were counted in a Burker chamber.
After centrifugation (4000 rev/min for 10
min), the radioactivity of the cells was
measured, first the gamma activity (1251) and
then, after dissolution of the cells in Soluene-
100 (Packard), the beta-activity (14C). Specific
quenching measurements were performed as
described under Double isotope studies
(above). The results are given in Table V.
Incorporation into melanin in vitro.-The
simultaneous incorporation of 125I-TU and
14C-TU into melanin synthesized in vitro was
studied both enzymatically (1) and by
auto-oxidation (2):
(1) Fifty ,umol L-DOPA, 106 disinte-
Substance
Na'251
125I-TU
Liver
2-6 (±1-4)
5 - 7 (±0 6)
Kidney
30 (±+03)
4- 7 (± 0 3)
Muscle
3 0 (± 0 8)
0 9 (± 0 5)
Serum
0-6 (±0 2)
0-4 (±0-1)
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TABLE V.-The in vitro uptake of radio-
activity in Harding-Passey melanoma
cells after a 24h culture period in a
medium containing a mixture of 125I-TU
and 14C-TU or 1251-PTU and 14C-TU
(100,000 ct/mm 125I and 100,000 disinte-
grated/min 14C respectively). The calcu-
lated ratios 125I-TU114C-TU and 125_
PTU/14C-TU in the cells as compared to
those of the medium (called 1) are given,
together with the estimated 1251.TU/125_1.
PTU based on their mutual relation to
14C-TU. Each value is the mean of 5
cultures.Figures in brackets =s.d.
Substances
125ITU/l4C-TU
25I-PTU/14C-TU
125I-TU/1251-PTU
Radioactivity
ratio in
melanoma cells
2- 7 (±0 2)
0 7 (±0 5)
5-6
grations/min 1251-TU (Batch B) and 106 dis-
integrations/min 14C-TU were dissolved in 15
ml 1/15M phosphate buffer, pH 6-8. Five
thousand units tyrosinase (Sigma) was then
added. Air was bubbled through the reaction
mixture for 40 h at room temperature,
followed by the addition of 1 ml 12M HCI.
(2) This synthesis was performed as in (1)
with two modifications: the pH of the
phosphate buffer was kept at 8-0 and no
tyrosinase was added.
The black precipitates (melanin) were
collected by centrifugation (35,000 g for 10
min), and then washed 4 times with 10 ml
distilled water. The first supernatant and the
washing media were mixed and their total
radioactivity was measured by gamma-
counting (1251-TU) and liquid scintillation
counting (14C-TU). The melanins were freeze-
dried and weighed and their content of
radioactivity was then mesured (Table VI).
Effects of thyroxine and potassium iodide
(KI) on the 125I-TU distribution.-Melanoma-
bearing mice were given either normal tap
water or water containing thyroxine (20
jug/ml for 14 days) and KI (2 mg/ml for 3
days) before they were administered 125I-TU
i.p. (22,900 ct/min/g body wt, Batch A). They
were then killed after 1, 4 and 7 days (3 for
each interval and treatment) and necropsied
for gamma-scintillation counting (Table VII).
Two mice (1 control and 1 treated) received
125I-TU (115,000 ct/min/g body wt) i.p. and
were killed after 4 days for autoradiography.
TABLE VI.-In vitro (cell-free) incorpora-
tion of125I-TU and 14C-TU into melanin
formed enzymatically (by tyrosinase) and
by auto-oxidation. For experimental
details, see Materials and Methods
Conditions of
melanin preparation
Enzyme (pH 6 8)
Auto-oxidation (pH 8.0)
Ratio
Incorporation of 125I-TU
Incorporation of 14C-TU
0 90
0 96
As the combined treatment with KI and
thyroxine indicated an effect not only on
thyroid uptake ofradioactivity but also on its
distribution in other organs, it was decided to
study the separate effects ofthe 2 treatments
in non-tumour-bearing mice. Five animals
were pretreated with KI (4 mg/ml) and 5
animals with thyroxine (40 ,ug/ml). Four
animals had no pretreatment. All the mice
were then injected with 400,000 ct/min/g
body wt of 1251-TU (Batch B), killed after 4
days and necropsied for gamma-scintillation
counting (Table VIII).
RESULTS
As can be seenintheFigure and in Table
IA, the 125I-TU was accumulated and
retained in melanotic melanomas of mice
in a similar way to thiouracil. Thus, at
long survival intervals, when most of the
drug was eliminated from the body, the
tumour tissues had considerably higher
concentrations of radioactivity than any
other tissue except the thyroid. In the
autoradiograms, the tumours showed a
mottled pattern, indicating regional dif-
ferences in the rate ofincorporation. When
tumour tissues were scraped off from
whole-body sections where the autoradio-
grams had shown the highest accumu-
lation, and the concentration in these
areas was compared to that of liver and
muscle ofthe same section, ratios ofup to
22 and 778 respectively were obtained
(Table IB).
Table II shows that 125I-PTU as well
was accumulated in melanotic melanomas,
although less so than 1251-TU. One reason
for this could be a more rapid metabolic
transformation or clearance from the body
of 1251-PTU than was observed for 1251-
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TABLE VIII.-Effect of KI or thyroxine on the tissue distribution of 125I-TU in non-
melanoma-bearing mice. Four animals in each group received KI (4 mg/ml in drink-
ing water for 7 days), thyroxine (40 jug/ml for 14 days) or normal tap water. The
animals were thengiven 125I-TU (400,000 ct/min/g bodywt) and were killed 4 days later.
The KI or thyroxine treatment continued during this 4-day interval. Figures in
brackets=s.d.
Pretreatment
No pretreatment
KI
Thyroxine
Thyroid
6079 (± 1166)
62 (±14)*
1430 ( ± 255)*
Liver
5 - 7 (± 0 6)
3-2 (+0.5)*
2-4 (+1-0)*
ct/min/mg tissue
_ --
Kidney
4- 7 (±0 3)
3-1 (±0 7)t
2-3 (±1-2)t
Muscle
09 (±+05)
0 3 (±O-1)T
1-4 (±06)
Serum
0-4 (±+01)
0 4 (± 0 2)
0-2 (±0-1)
Significantly different from controls (no pretreatment) by Student's t test:
* P-0. 001.
t P-0. 01.
tP-0 05.
TU. However, as shown in Table V,
125I-PTU was accumulated less in
melanoma cells in vitro as compared to
1251-TU, andthis most likelyoccurs in vivo
also.
Table II includes a group of mice that
receivedNa125J. As can be seen, the radio-
activity of most organs of these animals
differed from those of the animals that
received 125I-TU or 125J-PTU at the same
survival interval, and in particular there
was no apparent accumulation of 1251 in
melanomas compared with other tissues.
This indicates that most of the radio-
activity after 1251-TU or 125I-PTU
administration probably did not represent
free 1251
Administration of 1251-TU gave higher
radioactivity concentrations inthe thyroid
than would have been expected if 125I-TU
would accumulate in the thyroid to the
same extent as we had earlier observed for
14C-labelled thiouracil (Dencker et al.,
1982). This could be due to partial de-
iodination of 125I-TU. In order to roughly
calculate the percentage of the total 1251-
TU dose that had been deiodinated after 4
days, we injected Na-125I or 1251-TU to
groups ofnon-tumour-bearing mice (Table
III). The thyroid radioactivity after 1251-
TU dosing was considered to be due partly
to free 125I, and partly to unchanged 1251
TU. We then subtracted from the total
thyroidal radioactivity the expected 1251-
TU activity (as calculated from our
previous 14C-TU values). The rest should
mainly represent free 1251.* This activity
was approximately 14% of what was
obtained after Na'251 administration and
we maytherefore assume that around 14%
of the 1251-TU dose had been deiodinated
within 4 days.
The somewhat lower organ and tumour
radioactivity concentrations after 1251-TU
administration in comparison with our
previous 14C-thiouracil results and the
partial deiodination in vivo prompted us to
study 125I-TU and 14C-TU in the same
animals (double-isotope study; Table IV).
There were considerable variations in the
1251/14C ratios when different organs were
compared. With the exception of the
thyroid, where the fraction of free 125-1
specifically accumulated, all organs had a
lower 1251 than 14C radioactivity. In this
respect, tumour and muscle have an inter-
mediate position with a ratio of 0 35, the
liver and kidney somewhat higher (ratios
of 0-66 and 0-51 respectively) and lung and
eye lower (0.05 and 0.15 respectively). The
serum concentrations were too low to give
reliable ratios. A comparison with Table II
* % free iodine=(125I-TU)-(14C-TU) x 100
((Nal251)
()=concentration of radioactivity in tlhyroid.
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Fxo.-Whole-body autoradiograms of melanoma-bearing mice 24 h (A) and 14 days (B) respectively
afteri.p. injection of'1251-TU. (C) is the section corresponding to the autoradiogram in (B). Note the
accumulation in the melanomas. At 24 h, some radioactivity is still seen in other organs (especially
liver). In (B), only restricted tumour areas show high concentrations. These areas are probably the
older parts of the tumour, while the areas with a low concentration were formed between injection
and sacrifice.
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does not indicate that free 1251 essentially
contributred to the differences in the ratios
of the various organs.
Due to the variability ofdifferent organs
in their uptake of 125I-TU and 14C-TU, the
in vivo results could not unambiguously
determine whether 125-TU was incorpo-
rated into melanin to the same extent as
14C-TU. When melanoma cells were grown
in vitro for 24 h in a medium containing
both 1251-TU and 14C-TU, the resulting
1251/14Cratio was more than doubled in the
cells as compared to growing medium
(Table V). The 125I-PTU concentration
was only two-thirds of the 14C-TU when
compared under the same conditions. The
calculated ratio 1251-TU/1251-PTU in the
cells was 5-6.
Table VI shows that 1251-TU and 14C_
TU, when present together in a cell-free
medium where melanin is synthetized
from DOPA, are incorporated approxi-
mately to the same extent. This is true
both when the melanin is formed by auto-
oxidation and enzymatically through
tyrosinase activity.
In a clinical perspective it is essential to
bring down the accumulation of 1251-TU
and free 1251 in the thyroid. Pretreatment
of melanoma-bearing mice with thyroxine
and KI essentially decreased the thyroidal
accumulation of radioactivity after 1251-
TU administration, without changing the
concentration of radioactivity in the
ttumours compared with non-treated
animals (Table VII). In the autoradio-
grams from pretreated animals, the
thyroid concentration was usually at the
level of the tumour areas with highest
concentration. A considerable decrease in
radioactivity was observed also in livers
and kidneys, especially at 4 and 7 days,
and this effect was studied in more detail
in non-tumour-bearing mice (Table
VIII). The results show that KI butespeci-
ally thyroxine, when preadministered
separately, decreased liver and kidney
concentrations of radioactivity as
measured 4 days after administration of
1251-TU. KI pretreatment was much
rnore effective in decreasing the thyroid
accumulation of radioactivity (probably
mainly free 1251) than was thyroxine.
DISCUSSION
Our results indicate that iodo-thiouracil
and -propylthiouracil, when present in the
medium during formation of synthetic
melanin (using DOPA as the main pre-
cursor), are incorporated into the melanin
fornmed. This is also true for melanoma
cells grown in vitro. 1251-TU, 14C-TU and
125I-PTU are taken up in such cells in this
order. In a cell system, factors such as
membrane passage of the compounds and
their uptake into the cells are important in
relation to the extent of the final incorpo-
ration, and it is possible that this explains
the differences in uptake of these 3
compounds in our study.
If we consider the in vivo situation, a
large number of additional factors are
involved. The availability of the com-
pound in the extracellular space around
the tumour is then an additional
important factor for the rate of incor-
poration. This is dependent on the serum
concentration and the degree of protein-
binding in the plasma, which in turn
depends on the metabolic transformation
and excretion.
The in vivo double-isotope studies indi-
cate that 125I-TU leaves the body more
quickly than 14C-TU. This is partly due to
deiodination of the 125I-TU, but most
probably the intact molecule or meta-
bolite(s) of it is excreted more rapidly.
Consequently, the uptake in the mela-
nomas, as a percentage ofthe dose given to
the animal, was lower than that of14C-TU,
although the tumour/liver and tumour/
muscle ratios were in the same range for
the two analogues.
The in vivo results of the experiments
with 1251-PTU support the in vitro studies
which indicated that less 1251-PTU
accumulates in melanoma cells.
The use of a false precursor of melanin
instead of the physiological ones (mainly
tyrosine and DOPA) may appear
circuitous. Both these show a relatively
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low specificity for melanin. Tyrosine, being
an amino acid, is utilized in protein syn-
thesis in all parts of the body, and in our
studies (unpublished) very little iodo-
tyrosine was incorporated into melanin in
vivo. Meier et al. (1967) also failed to
demonstrate an incorporation of radio-
activity into melanomas after adminis-
tration of 1251-labelled melanin precursors
(5,6-diacetoxyindole). DOPA is taken up
in endocrine organs like the adrenal
medulla, in the pancreas and in gastric
mucosa (Rosell et al., 1963).
The localization in melanomas of poly-
cyclic amines (mainly radioiodine-labelled
quinolines) which are known to bind to
preformed melanin, has been attempted
with varying results (Potts, 1964; Beier-
waltes et al., 1968; Blois, 1968; Walsh &
Packer, 1971; Safi & Blanquet, 1973;
Packer et al., 1975). The most obvious dis-
advantage with this type of compound is
that they bind strongly to the melanin of
normal tissues, especially the eye. This
may cause ocular damage at higher doses,
or interfere with the radioactivity of an
ocular melanoma ifthey are used to detect
such tumours (Walsh & Packer, 1971).
Quinoline derivatives also accumulate in a
number of endocrine cell systems, as well
as in the kidney and bone marrow, and
show a long-term retention in the body
(Dencker et al., 1975, 1976).
The main advantage of 1251-TU is thus
that it is not accumulated in the
preformed melanin (especially in the eye),
and will not be accumulated and retained
in any other tissue of the body. The only
exception isthe thyroid, where the 1251-TU
as well as free 1251- (formed after the
partial deiodinationofthe 1251-TU) will be
markedly concentrated.
However, as shown here, this accum-
ulation was essentially eliminated by
proper pretreatment either with KI,
thyroxine or the combination of the two.
As there is adequate clinical experience in
the problem of radioiodine uptake in the
thyroid, we feel that iodothiouracil, label-
led with 1311 or 123J, may be ready for
clinical evaluation in the detection of
melanotic melanomas. Ifit turns out to be
as selective for melanomas in man as it is
in experimental animals, it may be tested
also as a therapeutic agent provided high
enough doses can be given to patients.
This study was supported by a grant (No. 1514)
from the Swedish Cancer Society.
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